NCT06297161
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Leukemia Myelogenous, +11 more
- Locations
-
- Pfizer New York New York, United States
Clinical trial condition
Explore clinical trials studying Chronic Leukemia Myelogenous. Study availability and eligibility vary by location and protocol.
NCT06297161